• Mashup Score: 4

    Patients with hematologic malignancies often require intensive and complex treatment regimens that result in substantial toxicities. They also face significant illness burden and health care utilization making social support critical to optimizing their outcomes [1,2]. Older adults with hematologic malignancies are arguably even more vulnerable, given their higher risk of treatment toxicity due to concurrent cytopenias and associated functional limitations requiring extensive social support.

    Tweet Tweets with this article
    • RT @JGeriOnc: Marital status, frailty, and survival in older adults with blood cancer https://t.co/ouppfIusTV @jorgeeavila @cdumonti @Willi…

  • Mashup Score: 0

    Search the USA Life Sciences Database and identify potential partners in the American Biotech, Pharma and Medtech industry

    Tweet Tweets with this article
    • Thank you to USA Life Sciences for recognizing the importance of the new @ASCO Guidelines for #GeriOnc! Based on large RCT's, the importance of conducting #GA and responding with #supportivecare interventions is stronger than ever. Less toxicity! https://t.co/FsiBHhSj2Y

  • Mashup Score: 8

    CarouselUncategorized New 2023 ASCO Geriatric Oncology Updated Guidelines: Practical Geriatric Assessment and Other Resources July 10, 2023July 17, 2023 Rolando Mantilla Welcome to CARG! The mission of the Cancer and Aging Research Group is to join geriatric oncology…

    Tweet Tweets with this article
    • The new #GeriOnc Guidelines from #ASCO are out!! Very proud to lead the esteemed group of researchers, clinicians, patient partners, nurses, and so many others to make this a reality. More to come! Follow https://t.co/l1x8DGCrDT for more updates. https://t.co/5GXnUbsMbn